Rathmann, Wolfgang
,
Strassburger, Klaus
Bongaerts, Brenda
Kuss, Oliver
Müssig, Karsten
Burkart, Volker
Szendroedi, Julia
Kotzka, Jörg
Knebel, Birgit
Al-Hasani, Hadi
Roden, Michael
Article History
Received: 24 July 2018
Accepted: 25 September 2018
First Online: 9 November 2018
Duality of interest
: WR reports receiving consulting fees for attending educational sessions or advisory boards from AstraZeneca, Boehringer Ingelheim and NovoNordisk and institutional research grants from NovoNordisk. MR reports receiving consulting fees from Boehringer Ingelheim, Eli Lilly, Merck, NovoNordisk, Poxel and Sanofi. No other potential conflicts of interest relevant to this article were reported.